{
    "title": "AstraZeneca lupus drug shows promise after set-back last year",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-7405943/AstraZeneca-lupus-drug-shows-promise-set-year.html",
    "date": "2019-08-29",
    "keywords": [
        "lupus",
        "treatment",
        "drug",
        "goal",
        "stage",
        "year",
        "tulip",
        "program",
        "sle",
        "disease",
        "plc",
        "thursday",
        "latestage",
        "study",
        "sign",
        "target",
        "trial",
        "drugmaker",
        "erythematosus",
        "httpsinreuterscomarticleusastrazenecaanifrolumabastrazenecalupusdrugfailstomeetmaingoalinstudyidinkcn1lg0mm",
        "data",
        "set",
        "executive",
        "vice",
        "president",
        "immune",
        "system",
        "tissue",
        "body",
        "foundation",
        "america",
        "astrazeneca",
        "race",
        "glaxosmithkline",
        "biotech",
        "company",
        "gsk",
        "approval",
        "benlysta",
        "century",
        "use",
        "april",
        "anifrolumab",
        "interferon",
        "protein",
        "inflammation",
        "reporting",
        "zainab",
        "hussain",
        "bengaluru",
        "editing",
        "bernard",
        "orr"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}